Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011500306> ?p ?o ?g. }
- W2011500306 endingPage "190" @default.
- W2011500306 startingPage "180" @default.
- W2011500306 abstract "Middle East respiratory syndrome (MERS), an emerging infectious disease caused by MERS coronavirus (MERS-CoV), has garnered worldwide attention as a consequence of its continuous spread and pandemic potential, making the development of effective vaccines a high priority. We previously demonstrated that residues 377–588 of MERS-CoV spike (S) protein receptor-binding domain (RBD) is a very promising MERS subunit vaccine candidate, capable of inducing potent neutralization antibody responses. In this study, we sought to identify an adjuvant that optimally enhanced the immunogenicity of S377–588 protein fused with Fc of human IgG (S377–588-Fc). Specifically, we compared several commercially available adjuvants, including Freund's adjuvant, aluminum, Monophosphoryl lipid A, Montanide ISA51 and MF59 with regard to their capacity to enhance the immunogenicity of this subunit vaccine. In the absence of adjuvant, S377–588-Fc alone induced readily detectable neutralizing antibody and T-cell responses in immunized mice. However, incorporating an adjuvant improved its immunogenicity. Particularly, among the aforementioned adjuvants evaluated, MF59 is the most potent as judged by its superior ability to induce the highest titers of IgG, IgG1 and IgG2a subtypes, and neutralizing antibodies. The addition of MF59 significantly augmented the immunogenicity of S377–588-Fc to induce strong IgG and neutralizing antibody responses as well as protection against MERS-CoV infection in mice, suggesting that MF59 is an optimal adjuvant for MERS-CoV RBD-based subunit vaccines." @default.
- W2011500306 created "2016-06-24" @default.
- W2011500306 creator A5008068714 @default.
- W2011500306 creator A5023492006 @default.
- W2011500306 creator A5032032857 @default.
- W2011500306 creator A5039694722 @default.
- W2011500306 creator A5040206102 @default.
- W2011500306 creator A5050951280 @default.
- W2011500306 creator A5051474892 @default.
- W2011500306 creator A5051968927 @default.
- W2011500306 creator A5053960511 @default.
- W2011500306 creator A5065582452 @default.
- W2011500306 creator A5069302796 @default.
- W2011500306 creator A5078895477 @default.
- W2011500306 creator A5081394669 @default.
- W2011500306 creator A5081759253 @default.
- W2011500306 date "2015-02-02" @default.
- W2011500306 modified "2023-10-17" @default.
- W2011500306 title "Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus" @default.
- W2011500306 cites W15133725 @default.
- W2011500306 cites W1515031832 @default.
- W2011500306 cites W1804248120 @default.
- W2011500306 cites W1823673912 @default.
- W2011500306 cites W1964334838 @default.
- W2011500306 cites W1965145857 @default.
- W2011500306 cites W1979127206 @default.
- W2011500306 cites W1979195886 @default.
- W2011500306 cites W1980785560 @default.
- W2011500306 cites W1982584872 @default.
- W2011500306 cites W1983472430 @default.
- W2011500306 cites W1985034407 @default.
- W2011500306 cites W1989525088 @default.
- W2011500306 cites W1990954596 @default.
- W2011500306 cites W1992055074 @default.
- W2011500306 cites W1993187419 @default.
- W2011500306 cites W1993945172 @default.
- W2011500306 cites W1994482345 @default.
- W2011500306 cites W1995696847 @default.
- W2011500306 cites W1998952429 @default.
- W2011500306 cites W2013090907 @default.
- W2011500306 cites W2016268672 @default.
- W2011500306 cites W2019317731 @default.
- W2011500306 cites W2024103022 @default.
- W2011500306 cites W2024196850 @default.
- W2011500306 cites W2024505041 @default.
- W2011500306 cites W2042592958 @default.
- W2011500306 cites W2044754526 @default.
- W2011500306 cites W2049845957 @default.
- W2011500306 cites W2049975503 @default.
- W2011500306 cites W2050259218 @default.
- W2011500306 cites W2052817467 @default.
- W2011500306 cites W2054135380 @default.
- W2011500306 cites W2054609914 @default.
- W2011500306 cites W2057004109 @default.
- W2011500306 cites W2061318760 @default.
- W2011500306 cites W2069215062 @default.
- W2011500306 cites W2072347337 @default.
- W2011500306 cites W2073765766 @default.
- W2011500306 cites W2078121682 @default.
- W2011500306 cites W2081861008 @default.
- W2011500306 cites W2083547697 @default.
- W2011500306 cites W2087971582 @default.
- W2011500306 cites W2095721550 @default.
- W2011500306 cites W2096729904 @default.
- W2011500306 cites W2101953995 @default.
- W2011500306 cites W2103758376 @default.
- W2011500306 cites W2105626573 @default.
- W2011500306 cites W2106921881 @default.
- W2011500306 cites W2108732610 @default.
- W2011500306 cites W2109115694 @default.
- W2011500306 cites W2112594941 @default.
- W2011500306 cites W2114485029 @default.
- W2011500306 cites W2119111857 @default.
- W2011500306 cites W2119248683 @default.
- W2011500306 cites W2120967846 @default.
- W2011500306 cites W2123996010 @default.
- W2011500306 cites W2126080553 @default.
- W2011500306 cites W2127106192 @default.
- W2011500306 cites W2128897591 @default.
- W2011500306 cites W2131369206 @default.
- W2011500306 cites W2138016704 @default.
- W2011500306 cites W2138564764 @default.
- W2011500306 cites W2141877163 @default.
- W2011500306 cites W2146242600 @default.
- W2011500306 cites W2149508011 @default.
- W2011500306 cites W2161687688 @default.
- W2011500306 cites W2164240579 @default.
- W2011500306 cites W2166867592 @default.
- W2011500306 cites W2169482835 @default.
- W2011500306 cites W279343580 @default.
- W2011500306 cites W2111201258 @default.
- W2011500306 doi "https://doi.org/10.1038/cmi.2015.03" @default.
- W2011500306 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4786625" @default.
- W2011500306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25640653" @default.
- W2011500306 hasPublicationYear "2015" @default.
- W2011500306 type Work @default.
- W2011500306 sameAs 2011500306 @default.
- W2011500306 citedByCount "108" @default.